{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:00:09Z","timestamp":1782846009943,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s10620-020-06716-2","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T18:18:32Z","timestamp":1606241912000},"page":"4058-4062","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt Creation"],"prefix":"10.1007","volume":"66","author":[{"given":"Marie-Louise","family":"Kloster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan Y.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murad M.","family":"Alqadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Lipnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Niemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron C.","family":"Gaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"6716_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.27210","volume":"60","author":"H Vilstrup","year":"2014","unstructured":"Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology.. 2014;60:715\u2013735.","journal-title":"Hepatology."},{"key":"6716_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1055\/s-0035-1549376","volume":"32","author":"PV Suhocki","year":"2015","unstructured":"Suhocki PV, Lungren MP, Kapoor B, Kim CY. Transjugular intrahepatic portosystemic shunt complications: prevention and management. Semin Intervent Radiol.. 2015;32:123\u2013132.","journal-title":"Semin Intervent Radiol."},{"key":"6716_CR3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jvir.2014.08.012","volume":"26","author":"RC Gaba","year":"2015","unstructured":"Gaba RC, Parvinian A, Minocha J, et al. Should transjugular intrahepatic portosystemic shunt stent grafts be underdilated? J Vasc Interv Radiol.. 2015;26:382\u2013387.","journal-title":"J Vasc Interv Radiol."},{"key":"6716_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jvir.2014.10.021","volume":"26","author":"CC Pieper","year":"2015","unstructured":"Pieper CC, Sprinkart AM, Nadal J, et al. Postinterventional passive expansion of partially dilated transjugular intrahepatic portosystemic shunt stents. J Vasc Interv Radiol.. 2015;26:388\u2013394.","journal-title":"J Vasc Interv Radiol."},{"key":"6716_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jvir.2016.06.023","volume":"28","author":"CC Pieper","year":"2017","unstructured":"Pieper CC, Jansen C, Meyer C, et al. Prospective evaluation of passive expansion of partially dilated transjugular intrahepatic portosystemic shunt stent grafts-a three-dimensional sonography study. J Vasc Interv Radiol.. 2017;28:117\u2013125.","journal-title":"J Vasc Interv Radiol."},{"key":"6716_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.4254\/wjh.v9.i12.603","volume":"9","author":"MC Hsu","year":"2017","unstructured":"Hsu MC, Weber CN, Stavropoulos SW, et al. Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes. World J Hepatol.. 2017;9:603\u2013612.","journal-title":"World J Hepatol."},{"key":"6716_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejrad.2017.01.032","volume":"89","author":"A Mollaiyan","year":"2017","unstructured":"Mollaiyan A, Bettinger D, Rossle M. The underdilation of nitinol stents at TIPS implantation: solution or illusion? Eur J Radiol.. 2017;89:123\u2013128.","journal-title":"Eur J Radiol."},{"key":"6716_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00270-018-2040-y","volume":"42","author":"R Miraglia","year":"2019","unstructured":"Miraglia R, Maruzzelli L, Di Piazza A, et al. Transjugular intrahepatic portosystemic shunt using the new gore Viatorr Controlled Expansion endoprosthesis: prospective, single-center, preliminary experience. Cardiovasc Intervent Radiol.. 2019;42:78\u201386.","journal-title":"Cardiovasc Intervent Radiol."},{"key":"6716_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jvir.2011.10.015","volume":"23","author":"RC Gaba","year":"2012","unstructured":"Gaba RC, Omene BO, Podczerwinski ES, et al. TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period. J Vasc Interv Radiol.. 2012;23:227\u2013235.","journal-title":"J Vasc Interv Radiol."},{"key":"6716_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5152\/dir.2014.13415","volume":"20","author":"A Parvinian","year":"2014","unstructured":"Parvinian A, Bui JT, Knuttinen MG, Minocha J, Gaba RC. Transjugular intrahepatic portosystemic shunt for the treatment of medically refractory ascites. Diagn Interv Radiol.. 2014;20:58\u201364.","journal-title":"Diagn Interv Radiol."},{"key":"6716_CR11","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.jvir.2017.06.019","volume":"28","author":"O Khalilzadeh","year":"2017","unstructured":"Khalilzadeh O, Baerlocher MO, Shyn PB, et al. Proposal of a new adverse event classification by the society of interventional radiology standards of practice committee. J Vasc Interv Radiol.. 2017;28:1432\u20131437.","journal-title":"J Vasc Interv Radiol."},{"key":"6716_CR12","first-page":"9149065","volume":"2020","author":"J Liu","year":"2020","unstructured":"Liu J, Wehrenberg-Klee EP, Bethea ED, Uppot RN, Yamada K, Ganguli S. Transjugular intrahepatic portosystemic shunt placement for portal hypertension: meta-analysis of safety and efficacy of 8\u00a0mm vs. 10\u00a0mm stents. Gastroenterol Res Pract.. 2020;2020:9149065.","journal-title":"Gastroenterol Res Pract."},{"key":"6716_CR13","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10620-014-3391-0","volume":"60","author":"LC Casadaban","year":"2015","unstructured":"Casadaban LC, Parvinian A, Minocha J, et al. Clearing the confusion over hepatic encephalopathy after TIPS creation: incidence, prognostic factors, and clinical outcomes. Dig Dis Sci.. 2015;60:1059\u20131066. https:\/\/doi.org\/10.1007\/s10620-014-3391-0.","journal-title":"Dig Dis Sci."},{"key":"6716_CR14","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1007\/s00270-020-02512-7","volume":"43","author":"WM Coronado","year":"2020","unstructured":"Coronado WM, Ju C, Bullen J, Kapoor B. Predictors of occurrence and risk of hepatic encephalopathy after TIPS creation: a 15-year experience. Cardiovasc Intervent Radiol.. 2020;43:1156\u20131164.","journal-title":"Cardiovasc Intervent Radiol."},{"key":"6716_CR15","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1111\/liv.12956","volume":"35","author":"K Pereira","year":"2015","unstructured":"Pereira K, Carrion AF, Martin P, et al. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy. Liver Int.. 2015;35:2487\u20132494.","journal-title":"Liver Int."},{"key":"6716_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1051-0443(96)70775-3","volume":"7","author":"EM Walser","year":"1996","unstructured":"Walser EM, Harris VM, Harman JT, Park HM, Siddiqui AR. Quantification of intrahepatic portosystemic shunting after placement of a transjugular intrahepatic portosystemic shunt. J Vasc Interv Radiol.. 1996;7:263\u2013267.","journal-title":"J Vasc Interv Radiol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06716-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-020-06716-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06716-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T02:37:42Z","timestamp":1634092662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-020-06716-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["6716"],"URL":"https:\/\/doi.org\/10.1007\/s10620-020-06716-2","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"assertion":[{"value":"12 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Disclosures not related to this work: Ron C. Gaba receives research support from Guerbet USA LLC, Janssen Research and Development LLC, the United States Department of Defense, and the United States National Institutes of Health. He serves as a consultant for Sus Clinicals, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}